Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Syringe driver in terminal care.

S B Dover

    British Medical Journal (Clinical Research Ed.)
    |February 28, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Continuous subcutaneous infusions using syringe drivers are effective for terminal care when oral medication is not possible. This method facilitates domiciliary care by overcoming challenges in providing regular parenteral analgesia.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Lofepramine--a safe anti-depressant in acute hepatic porphyria?

    Journal of psychopharmacology (Oxford, England)·2012
    Same author

    Safety of general anaesthesia and surgery in acute hepatic porphyria.

    Gut·1994
    Same author

    Tin protoporphyrin prolongs the biochemical remission produced by heme arginate in acute hepatic porphyria.

    Gastroenterology·1993
    Same author

    Haem-arginate plus tin-protoporphyrin for acute hepatic porphyria.

    Lancet (London, England)·1991
    Same author

    "Patients with terminal cancer" who have neither terminal illness nor cancer.

    British medical journal (Clinical research ed.)·1987
    Same author

    Study of "discharge communications" from hospital.

    British medical journal (Clinical research ed.)·1986
    Same journal

    Early retirement for consultants.

    British medical journal (Clinical research ed.)·2010
    Same journal

    From COMAR: Essential troika of teaching, research, and clinical care.

    British medical journal (Clinical research ed.)·2010
    Same journal

    Parliament's two way pull on the NHS.

    British medical journal (Clinical research ed.)·2010
    Same journal

    Conference Report: After the summit.

    British medical journal (Clinical research ed.)·2010
    Same journal

    Council election: South Western regional vacancy 1988-90.

    British medical journal (Clinical research ed.)·2010
    Same journal

    Health managers support taxation based service.

    British medical journal (Clinical research ed.)·2010
    See all related articles

    Area of Science:

    • Palliative Care
    • Pharmacology
    • Oncology

    Background:

    • Parenteral drug administration is crucial for patients unable to take oral medications, especially in terminal care.
    • Syringe drivers offer a viable solution for continuous drug delivery.
    • Diamorphine is frequently used due to its solubility.

    Purpose of the Study:

    • To highlight the utility of continuous subcutaneous infusions via syringe driver in terminal care.
    • To discuss the administration of adjunctive medications alongside opioids.
    • To emphasize the benefits for home-based palliative care.

    Main Methods:

    • Utilizing continuous subcutaneous infusions (CSIs) via syringe driver pumps.
    • Administering diamorphine as the primary opioid.

    Related Experiment Videos

  • Co-administering other necessary medications like antiemetics, anticholinergics, sedatives, and steroids as needed.
  • Main Results:

    • Syringe driver infusions are frequently and successfully employed in terminal care.
    • This method allows for the administration of various drug classes beyond opioids.
    • It significantly simplifies parenteral analgesia delivery in domiciliary settings.

    Conclusions:

    • Continuous subcutaneous infusions via syringe driver are a successful and practical method for managing symptoms in terminal illness.
    • The technique is particularly beneficial for home care, addressing challenges of regular parenteral medication delivery.
    • It enables comprehensive symptom management through co-administration of multiple drug types.